Suppr超能文献

欢迎来到《个性化医疗杂志》:一个用于优化个体医疗保健研究的新开放获取平台。

Welcome to the Journal of Personalized Medicine: A New Open-Access Platform for Research on Optimal Individual Healthcare.

作者信息

Meyer Urs A

机构信息

Founding Editor-in-Chief of Journal of Personalized Medicine, Pharmacology/Neurobiology, Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland.

出版信息

J Pers Med. 2011 Mar 28;1(1):1-4. doi: 10.3390/jpm1010001.

Abstract

A new vision of personalized medicine or personalized healthcare has evolved as a consequence of remarkable recent advances in technologies that allow to look at individual variation across the entire human genome and to identify personal risk factors behind many diseases and responses to therapy. These advances have greatly increased our understanding of how interactions between the entire genome and nongenomic factors result in health and disease and in therapeutic response. The challenge is now to translate this knowledge into benefits for the individual patient. I expect the Journal of Personalized Medicine to become the premier venue for the rapid and freely accessible publication of high quality manuscripts dealing with this vision for scientists around the world. [...].

摘要

由于近期技术取得了显著进展,能够对整个人类基因组中的个体差异进行研究,并识别许多疾病背后的个人风险因素以及对治疗的反应,个性化医疗或个性化保健的新愿景由此应运而生。这些进展极大地增进了我们对整个基因组与非基因组因素之间的相互作用如何导致健康与疾病以及治疗反应的理解。现在面临的挑战是将这些知识转化为个体患者的益处。我期望《个性化医疗杂志》成为一个首要平台,能够快速且免费地发表高质量稿件,供世界各地的科学家探讨这一愿景。[...]

相似文献

2
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.
3
Personalized medicine: a personal view.
Clin Pharmacol Ther. 2012 Mar;91(3):373-5. doi: 10.1038/clpt.2011.238.
7
Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
Complement Ther Med. 2012 Feb-Apr;20(1-2):93-9. doi: 10.1016/j.ctim.2011.10.007. Epub 2011 Nov 30.
8
A new journal - "Theoretical Biology and Medical Modelling".
Theor Biol Med Model. 2005 Jun 12;2:21. doi: 10.1186/1742-4682-2-21.

本文引用的文献

1
2010 FDA drug approvals.
Nat Rev Drug Discov. 2011 Feb;10(2):82-5. doi: 10.1038/nrd3370.
2
Get ready for the flood of fetal gene screening.
Nature. 2011 Jan 20;469(7330):289-91. doi: 10.1038/469289a.
3
Human genome: Genomes by the thousand.
Nature. 2010 Oct 28;467(7319):1026-7. doi: 10.1038/4671026a.
4
Clinical assessment incorporating a personal genome.
Lancet. 2010 May 1;375(9725):1525-35. doi: 10.1016/S0140-6736(10)60452-7.
5
Pharmacogenetics - five decades of therapeutic lessons from genetic diversity.
Nat Rev Genet. 2004 Sep;5(9):669-76. doi: 10.1038/nrg1428.
6
Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.
Lancet. 1990 Sep 1;336(8714):529-32. doi: 10.1016/0140-6736(90)92086-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验